Indeed, double labeling of a gonadotroph tumor with EM66 and LHβ antibodies revealed that EM66 immunoreactivity is localized to gonadotroph cells whereas HPLC analysis combined with RIA detection resolved a single immunoreactive peak co-eluting with synthetic EM66 in gonadotroph tumor extracts. This evidence concerns the gene SCG2 and neoplasm.